Clinical Trials Browser

Interventional × Neurilemmoma × Bevacizumab × Clear all

NCT01083966 2025-04-09

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Phase 1 Suspended

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic